Is CINC or JNJ a better dividend investment in 2026?

CINC currently yields 6.88% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: CINC offers higher current income.

What is the dividend yield difference between CINC and JNJ?

CINC has a forward dividend yield of 6.88% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 3.52 percentage points.

Home › Compare › CINC vs JNJ

CINC vs JNJ: Dividend Comparison 2026

CINC yields 6.88% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CINC wins by $11.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CINC

● Live price

6.88%

Share price

$29.06

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.5K

Annual income

$1,065.72

Full CINC calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — CINC vs JNJ

📍 CINC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CINC	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CINC + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CINC pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CINC

Annual income on $10K today (after 15% tax)

$585.00/yr

After 10yr DRIP, annual income (after tax)

$905.86/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, CINC beats the other by $202.25/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CINC + JNJ for your $10,000?

CINC: 50%JNJ: 50%

100% JNJ50/50100% CINC

Portfolio after 10yr

$25.8K

Annual income

$946.75/yr

Blended yield

3.67%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CINC

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$48.50

+66.9% upside vs current

Range: $30.00 — $73.00

Altman Z

75.2

Piotroski

2/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CINC buys

JNJ buys

No recent congressional trades found for CINC or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCINCJNJ

Forward yield	6.88% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$31.5K ✓	$20.0K
Annual income after 10y	$1,065.72 ✓	$827.78
Total dividends collected	$8.8K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy
Analyst price target	$48.50	$228.73 ✓

Year-by-year: CINC vs JNJ ($10,000, DRIP)

Year	CINC Portfolio	CINC Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,388	$688.23	$10,676	$355.77	+$712.00 → CINC
2	$12,918	$732.50	$11,407	$389.39	+$1.5K → CINC
3	$14,599	$776.53	$12,198	$426.53	+$2.4K → CINC
4	$16,441	$820.16	$13,056	$467.62	+$3.4K → CINC
5	$18,455	$863.22	$13,987	$513.12	+$4.5K → CINC
6	$20,652	$905.58	$14,998	$563.56	+$5.7K → CINC
7	$23,045	$947.11	$16,098	$619.52	+$6.9K → CINC
8	$25,646	$987.70	$17,295	$681.69	+$8.4K → CINC
9	$28,468	$1,027.26	$18,599	$750.82	+$9.9K → CINC
10	$31,527	$1,065.72	$20,022	$827.78	+$11.5K → CINC

CINC vs JNJ: Complete Analysis 2026

CINC — Stock

CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. CinCor Pharma, Inc. has a license agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.

Full CINC Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this CINC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CINC vs SCHD CINC vs JEPI CINC vs O CINC vs KO CINC vs MAIN CINC vs ABBV CINC vs MRK CINC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.